Home » Topics » Cancer, BioWorld Science

Cancer, BioWorld Science
RSS

Pro-Pharmaceuticals commences NDA filing for Davanat

Feb. 8, 2007

European label extension sought for Evoltra for elderly patients with AML

Feb. 8, 2007

Romidepsin studied with bortezomib for relapsed/refractory multiple myeloma

Feb. 8, 2007

Genta to appeal Genasense non-approvable letter in CLL

Feb. 8, 2007

European orphan drug designation for Fodosine in CTCL

Feb. 8, 2007

Elacyt to be studied for metastatic colorectal cancer

Feb. 8, 2007

Glufosfamide studied in new phase II trial for recurrent, sensitive SCLC

Feb. 8, 2007

Favorable data on the gemcitabine/Myocet combination from a phase II trial

Feb. 8, 2007

Clinical data on vinflunine in metastatic breast cancer presented

Feb. 8, 2007

WP-760 displays selectivity against melanoma cells in vitro

Feb. 8, 2007

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 17, 2026.
Biohaven reports details on discovery of BHV-2100
BioWorld Science
Transient receptor potential melastatin 3 (TRPM3) is a calcium-permeable TRP channel that is highly expressed in somatosensory neurons, including nociceptors of...
New GABA(B) receptor PAMs revealed in Addex Pharma patents
BioWorld Science
Addex Pharma SA has disclosed new GABA(B) receptor positive allosteric modulators (PAMs) potentially useful for the treatment of chronic cough, urinary...
Meta-analysis: Anti-amyloid Alzheimer’s drugs not ‘clinically meaningful’
BioWorld
The ongoing controversy over the effectiveness of anti-amyloid drugs is about to get more heated, after a review of clinical trials showed statistically...
Novel caspase-2 inhibitor shows in vivo neuroprotective effects
BioWorld Science
Caspase-2-mediated cleavage of tau at Asp314 generates a neurotoxic fragment, Δtau314, that drives early synaptic dysfunction in Alzheimer’s disease (AD) and...